Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1047

1.

Impact of Hepatic Artery Size Mismatch between Donor and Recipient on Outcomes after Living-donor Liver Transplantation using the Right Lobe.

Harada N, Yoshizumi T, Uchiyama H, Soejima Y, Ikegami T, Itoh S.

Clin Transplant. 2018 Nov 8:e13444. doi: 10.1111/ctr.13444. [Epub ahead of print]

PMID:
30408259
2.

Impact of Osteopenia in Liver Cirrhosis: Special Reference to Standard Bone Mineral Density with Age.

Toshima T, Yoshizumi T, Ikegami T, Harada N, Itoh S, Mano Y, Motomura T, Soejima Y, Maehara Y.

Anticancer Res. 2018 Nov;38(11):6465-6471. doi: 10.21873/anticanres.13009.

PMID:
30396973
3.

Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.

Itokawa N, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, Abe H, Okubo T, Arai T, Iwashita AN, Kondo C, Mikami S, Asano T, Matsuzaki Y, Toyoda H, Kumada T, Iio E, Tanaka Y, Iwakiri K.

Hepatol Res. 2018 Oct 11. doi: 10.1111/hepr.13256. [Epub ahead of print]

PMID:
30307682
4.

Slow Gait Speed Is a Risk Factor for Complications After Hepatic Resection.

Itoh S, Yoshizumi T, Sakata K, Motomura T, Mano Y, Toshima T, Harimoto N, Harada N, Ikegami T, Soejima Y, Kusaba R, Kamishima T, Nishie A, Maehara Y.

J Gastrointest Surg. 2018 Oct 8. doi: 10.1007/s11605-018-3993-5. [Epub ahead of print]

PMID:
30298420
5.

Spatial Overlap of Claudin- and Phosphatidylinositol Phosphate-Binding Sites on the First PDZ Domain of Zonula Occludens 1 Studied by NMR.

Hiroaki H, Satomura K, Goda N, Nakakura Y, Hiranuma M, Tenno T, Hamada D, Ikegami T.

Molecules. 2018 Sep 26;23(10). pii: E2465. doi: 10.3390/molecules23102465.

6.

Feasibility of all-in-one venoplasty with venous cuff using opened round ligament for right lobe graft in living donor liver transplantation.

Toshima T, Yoshizumi T, Simokawa M, Ikegami T, Harada N, Itoh S, Mano Y, Motomura T, Soejima Y, Maehara Y.

Liver Transpl. 2018 Sep 19. doi: 10.1002/lt.25339. [Epub ahead of print]

PMID:
30230163
7.

[Evaluation of Clinical Features and Growth Hormone Deficiency in Short Children Born Small For Gestational Age].

Ikegami T, Araki S, Kuwamura M, Taku A, Saito R, Goto M, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y, Kusuhara K.

J UOEH. 2018;40(3):253-257. doi: 10.7888/juoeh.40.253. Japanese.

8.

A Pediatric Case of Graves' Hyperthyroidism with Associated Glucose Intolerance Detected by a Urine Glucose Screening Program at School.

Ikegami T, Yamamoto Y, Goto M, Kawagoe R, Kawada Y, Kusuhara K.

J UOEH. 2018;40(3):231-236. doi: 10.7888/juoeh.40.231.

9.

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.

Okabe H, Yoshizumi T, Yamashita YI, Imai K, Hayashi H, Nakagawa S, Itoh S, Harimoto N, Ikegami T, Uchiyama H, Beppu T, Aishima S, Shirabe K, Baba H, Maehara Y.

PLoS One. 2018 Sep 14;13(9):e0203856. doi: 10.1371/journal.pone.0203856. eCollection 2018.

10.

Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation.

Harada N, Yoshizumi T, Ikegami T, Itoh S, Furusho N, Kato M, Shimoda S, Fukuhara T, Soejima Y, Maehara Y.

Anticancer Res. 2018 Sep;38(9):5513-5520. doi: 10.21873/anticanres.12885.

PMID:
30194210
11.

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature.

Iseda N, Yoshizumi T, Toshima T, Morinaga A, Tomiyama T, Takahashi J, Motomura T, Mano Y, Itoh S, Harada N, Ikegami T, Soejima Y.

Surg Case Rep. 2018 Aug 29;4(1):101. doi: 10.1186/s40792-018-0505-5.

12.

A novel chitin-binding mode of the chitin-binding domain of chitinase A1 from Bacillus circulans WL-12 revealed by solid-state NMR.

Tanaka H, Akutsu H, Yabuta I, Hara M, Sugimoto H, Ikegami T, Watanabe T, Fujiwara T.

FEBS Lett. 2018 Sep;592(18):3173-3182. doi: 10.1002/1873-3468.13226. Epub 2018 Sep 1.

PMID:
30125342
13.

Detection of human papillomavirus in branchial cleft cysts.

Ikegami T, Uehara T, Deng Z, Kondo S, Maeda H, Kiyuna A, Agena S, Hirakawa H, Yamashita Y, Ganaha A, Suzuki M.

Oncol Lett. 2018 Aug;16(2):1571-1578. doi: 10.3892/ol.2018.8827. Epub 2018 May 30.

14.

Hemilaterally masked arterial spin labeling by intentional magnetic field changes in the labeling area due to placement of material with high susceptibility.

Hagiwara H, Nakajima Y, Ikegami T, Kinno Y, Kumada M.

PLoS One. 2018 Jul 12;13(7):e0200648. doi: 10.1371/journal.pone.0200648. eCollection 2018.

15.

The characteristics of patients with hypermagnesemia who underwent emergency hemodialysis.

Nishikawa M, Shimada N, Kanzaki M, Ikegami T, Fukuoka T, Fukushima M, Asano K.

Acute Med Surg. 2018 Feb 21;5(3):222-229. doi: 10.1002/ams2.334. eCollection 2018 Jul.

16.

High-performance liquid chromatographic separation of 8-aminopyrene-1,3,6-trisulfonic acid labeled N-glycans using a functional tetrazole hydrophilic interaction liquid chromatography column.

Yamamoto S, Kinoshita M, Ikegami T, Suzuki S.

J Chromatogr A. 2018 Sep 7;1566:44-50. doi: 10.1016/j.chroma.2018.06.050. Epub 2018 Jun 20.

PMID:
29937119
17.

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature.

Yugawa K, Yoshizumi T, Harada N, Motomura T, Harimoto N, Itoh S, Ikegami T, Soejima Y, Maehara Y.

Surg Case Rep. 2018 Jun 19;4(1):60. doi: 10.1186/s40792-018-0468-6.

18.

Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus.

Escaffre O, Hill T, Ikegami T, Juelich TL, Smith JK, Zhang L, Perez DE, Atkins C, Park A, Lawrence WS, Sivasubramani SK, Peel JE, Peterson JW, Lee B, Freiberg AN.

J Infect Dis. 2018 Oct 5;218(10):1602-1610. doi: 10.1093/infdis/jiy357.

PMID:
29912426
19.

Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.

Imai D, Yoshizumi T, Sakata K, Ikegami T, Itoh S, Harada N, Motomura T, Toshima T, Mano Y, Soejima Y, Maehara Y.

Transplantation. 2018 Sep;102(9):e382-e391. doi: 10.1097/TP.0000000000002324.

PMID:
29912047
20.

Method optimization of hydrophilic interaction chromatography separation of nucleotides using design of experiment approaches I: Comparison of several zwitterionic columns.

Arase S, Kimura S, Ikegami T.

J Pharm Biomed Anal. 2018 Sep 5;158:307-316. doi: 10.1016/j.jpba.2018.05.014. Epub 2018 May 12.

PMID:
29909320
21.

Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.

Muto J, Sugiyama M, Shirabe K, Mukaide M, Kirikae-Muto I, Ikegami T, Yoshizumi T, Yamashita YI, Maehara Y, Mizokami M.

Ann Hepatol. 2018 July - August ,;17(4):596-603. doi: 10.5604/01.3001.0012.0927.

22.

Lymphocyte-to-Monocyte Ratio Is a Predictor of Survival After Liver Transplantation for Hepatocellular Carcinoma.

Mano Y, Yoshizumi T, Yugawa K, Ohira M, Motomura T, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Maehara Y.

Liver Transpl. 2018 Nov;24(11):1603-1611. doi: 10.1002/lt.25204.

PMID:
29893464
23.

Prediction error induced motor contagions in human behaviors.

Ikegami T, Ganesh G, Takeuchi T, Nakamoto H.

Elife. 2018 May 29;7. pii: e33392. doi: 10.7554/eLife.33392.

24.

Favipiravir (T-705) protects against Nipah virus infection in the hamster model.

Dawes BE, Kalveram B, Ikegami T, Juelich T, Smith JK, Zhang L, Park A, Lee B, Komeno T, Furuta Y, Freiberg AN.

Sci Rep. 2018 May 15;8(1):7604. doi: 10.1038/s41598-018-25780-3.

25.

Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial.

Kaido T, Shinoda M, Inomata Y, Yagi T, Akamatsu N, Takada Y, Ohdan H, Shimamura T, Ogura Y, Eguchi S, Eguchi H, Ogata S, Yoshizumi T, Ikegami T, Yamamoto M, Morita S, Uemoto S.

Nutrition. 2018 Oct;54:68-75. doi: 10.1016/j.nut.2018.02.022. Epub 2018 Mar 20.

PMID:
29747091
26.

Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.

Murakami M, Iwamoto J, Honda A, Tsuji T, Tamamushi M, Ueda H, Monma T, Konishi N, Yara S, Hirayama T, Miyazaki T, Saito Y, Ikegami T, Matsuzaki Y.

Inflamm Bowel Dis. 2018 Apr 23;24(5):1035-1044. doi: 10.1093/ibd/izy022.

PMID:
29688473
27.

Publisher Correction: Immediate tool incorporation processes determine human motor planning with tools.

Ganesh G, Yoshioka T, Osu R, Ikegami T.

Nat Commun. 2018 Apr 10;9:16209. doi: 10.1038/ncomms16209.

28.

X-ray structure of an asymmetrical trimeric ferredoxin-photosystem I complex.

Kubota-Kawai H, Mutoh R, Shinmura K, Sétif P, Nowaczyk MM, Rögner M, Ikegami T, Tanaka H, Kurisu G.

Nat Plants. 2018 Apr;4(4):218-224. doi: 10.1038/s41477-018-0130-0. Epub 2018 Apr 2.

PMID:
29610537
29.

Change in muscle volume after steroid therapy in patients with myositis assessed using cross-sectional computed tomography.

Nawata T, Kubo M, Nomura T, Oishi K, Shiragami K, Ikegami T, Okada M, Kobayashi S, Yano M.

BMC Musculoskelet Disord. 2018 Mar 27;19(1):93. doi: 10.1186/s12891-018-2008-8.

30.

Validity of the Japan Acuity and Triage Scale in adults: a cohort study.

Kuriyama A, Ikegami T, Kaihara T, Fukuoka T, Nakayama T.

Emerg Med J. 2018 Jun;35(6):384-388. doi: 10.1136/emermed-2017-207214. Epub 2018 Mar 13.

PMID:
29535086
31.

Rift Valley fever vaccines: current and future needs.

Dungu B, Lubisi BA, Ikegami T.

Curr Opin Virol. 2018 Apr;29:8-15. doi: 10.1016/j.coviro.2018.02.001. Epub 2018 Mar 4. Review.

PMID:
29514112
32.

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy.

Nawata T, Kubo M, Fujii S, Shiragami K, Ikegami T, Kobayashi S, Hisano S, Yano M.

Intern Med. 2018 Jul 15;57(14):2067-2070. doi: 10.2169/internalmedicine.0304-17. Epub 2018 Feb 28.

33.

Appropriate Use of Stents to Prevent Biliary Complications after Living Donor Liver Transplantation.

Ikegami T, Yoshizumi T, Soejima Y, Ohira M, Maehara Y.

J Am Coll Surg. 2018 Feb;226(2):201. doi: 10.1016/j.jamcollsurg.2017.10.009. No abstract available.

PMID:
29389377
34.

Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Harimoto N, Yoshizumi T, Fujimoto Y, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2018 Aug;42(8):2606-2616. doi: 10.1007/s00268-018-4493-1.

PMID:
29372372
35.

Shared Mechanisms in the Estimation of Self-Generated Actions and the Prediction of Other's Actions by Humans.

Ikegami T, Ganesh G.

eNeuro. 2017 Jan 13;4(6). pii: ENEURO.0341-17.2017. doi: 10.1523/ENEURO.0341-17.2017. eCollection 2017 Nov-Dec.

36.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.

Arai T, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, Abe H, Okubo T, Itokawa N, Kondo C, Mikami S, Asano T, Chuganji Y, Matsuzaki Y, Toyoda H, Kumada T, Iio E, Tanaka Y, Iwakiri K.

Hepatol Res. 2018 Jun;48(7):549-555. doi: 10.1111/hepr.13058. Epub 2018 Feb 21.

PMID:
29316062
37.

Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.

Harimoto N, Yugawa K, Ikegami T, Ohira M, Mano Y, Motomura T, Toshima T, Itoh S, Harada N, Soejima Y, Yoshizumi T, Maehara Y, Oda Y.

J Gastroenterol Hepatol. 2018 Jan;33(1):9. doi: 10.1111/jgh.13975. No abstract available.

PMID:
29284078
38.

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment.

Hirayama T, Ikegami T, Honda A, Miyazaki T, Yara SI, Kohjima M, Nakamuta M, Matsuzaki Y.

Intern Med. 2018 May 1;57(9):1219-1227. doi: 10.2169/internalmedicine.9479-17. Epub 2017 Dec 27.

39.

Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.

Ikegami T, Balogh A, Nishiyama S, Lokugamage N, Saito TB, Morrill JC, Shivanna V, Indran SV, Zhang L, Smith JK, Perez D, Juelich TL, Morozov I, Wilson WC, Freiberg AN, Richt JA.

PLoS One. 2017 Dec 21;12(12):e0189250. doi: 10.1371/journal.pone.0189250. eCollection 2017.

40.

Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.

Atsukawa M, Tsubota A, Kato K, Abe H, Shimada N, Asano T, Ikegami T, Koeda M, Okubo T, Arai T, Nakagawa-Iwashita A, Yoshida Y, Hayama K, Itokawa N, Kondo C, Chuganji Y, Matsuzaki Y, Iwakiri K.

J Gastroenterol Hepatol. 2018 Jun;33(6):1256-1263. doi: 10.1111/jgh.14047. Epub 2018 Feb 19.

PMID:
29215154
41.

Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.

Motomura T, Yoshizumi T, Ohira M, Mano Y, Toshima T, Itoh S, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Transplant Proc. 2017 Dec;49(10):2409-2410. doi: 10.1016/j.transproceed.2017.09.014.

PMID:
29198692
42.

Potential effect of recombinant thrombomodulin on ischemia-reperfusion liver injury in rats.

Kimura K, Yoshizumi T, Inokuchi S, Itoh S, Motomura T, Mano Y, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Apr;48(5):391-396. doi: 10.1111/hepr.13005. Epub 2018 Jan 8.

PMID:
29168258
43.

Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.

Lokugamage N, Ikegami T.

NPJ Vaccines. 2017;2. pii: 20. doi: 10.1038/s41541-017-0021-9. Epub 2017 Jul 17.

44.

Methylation of CpG sites in the upstream regulatory region, physical status and mRNA expression of HPV-6 in adult-onset laryngeal papilloma.

Deng Z, Ikegami T, Kiyuna A, Zhang C, Zhang T, Matayoshi S, Uehara T, Maeda H, Suzuki M, Ganaha A.

Oncotarget. 2017 Aug 3;8(49):85368-85377. doi: 10.18632/oncotarget.19898. eCollection 2017 Oct 17.

45.

Reciprocal interactions between bile acids and gut microbiota in human liver diseases.

Ikegami T, Honda A.

Hepatol Res. 2018 Jan;48(1):15-27. doi: 10.1111/hepr.13001. Review.

PMID:
29150974
46.

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.

Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A, Kamishima T, Kusaba R, Shirabe K, Maehara Y.

Transplant Proc. 2017 Nov;49(9):2144-2152. doi: 10.1016/j.transproceed.2017.09.017.

PMID:
29149975
47.

Life as an emergent phenomenon: studies from a large-scale boid simulation and web data.

Ikegami T, Mototake YI, Kobori S, Oka M, Hashimoto Y.

Philos Trans A Math Phys Eng Sci. 2017 Dec 28;375(2109). pii: 20160351. doi: 10.1098/rsta.2016.0351.

PMID:
29133449
48.

Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease.

Iwamoto J, Murakami M, Konishi N, Monma T, Ueda H, Yara S, Hirayama T, Ikegami T, Honda A, Matsuzaki Y.

Intern Med. 2018 Feb 1;57(3):339-342. doi: 10.2169/internalmedicine.9322-17. Epub 2017 Nov 1.

49.

A Sensorimotor Signature of the Transition to Conscious Social Perception: Co-regulation of Active and Passive Touch.

Kojima H, Froese T, Oka M, Iizuka H, Ikegami T.

Front Psychol. 2017 Oct 13;8:1778. doi: 10.3389/fpsyg.2017.01778. eCollection 2017.

50.

Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Ly HJ, Nishiyama S, Lokugamage N, Smith JK, Zhang L, Perez D, Juelich TL, Freiberg AN, Ikegami T.

Vaccine. 2017 Dec 4;35(48 Pt B):6634-6642. doi: 10.1016/j.vaccine.2017.10.036. Epub 2017 Oct 20.

PMID:
29061350

Supplemental Content

Loading ...
Support Center